0.10Open0.10Pre Close0 Volume51 Open Interest7.50Strike Price0.00Turnover58.62%IV11.90%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier17DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.1657Delta0.2327Gamma84.00Leverage Ratio-0.0076Theta-0.0006Rho-13.92Eff Leverage0.0045Vega
Zymeworks Stock Discussion
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers
Zymeworks (Nasdaq: ZYME) announced that the FDA has cleared its investigational new drug (IND) application for ZW171, a novel 2+1 T-cell targeting bispecific antibody designed to treat mesothelin (MSLN)-expressing cancers such as ovarian cancer, non-small cell lung cancer, and mesothelioma. ZW171 aims to i...
⇨ held by 5 biopharma-focused hedge funds! 🔥
$Arcellx(ACLX.US)$ : Anito-cel (Ph 2)
$Adaptimmune Therapeutics(ADAP.US)$ : Afami-cel (PDUFA) ⏳
$Bicycle Therapeutics(BCYC.US)$ : BT8009 (Ph 1/2)
$Centessa Pharmaceuticals(CNTA.US)$ : LB101 (Ph 1/2)
$Day One Biopharmaceuticals(DAWN.US)$ : Tovorafenib (PDUFA) (check comments for details)
$Fate Therapeutics(FATE.US)$ : FT576 (Ph 1)
$Fusion Pharmaceuticals(FUSN.US)$ : FPI-2265 (Ph 2)
$GRCL: ...
youtube.com/emb...
$Abbott Laboratories(ABT.US)$ $Agrify(AGFY.US)$ $Tesla(TSLA.US)$ $Amprius Technologies(AMPX.US)$ $Olaplex(OLPX.US)$ $Momentive Global(MNTV.US)$ $SOBR Safe(SOBR.US)$ $Zymeworks(ZYME.US)$ $Generac(GNRC.US)$ $Netflix(NFLX.US)$
No comment yet